Effect of femoral component offset on polyethylene wear in total hip arthroplasty.

Seventeen staged, bilateral total hip arthroplasties performed in 17 patients were reviewed to compare side-to-side polyethylene wear. Implants used on both sides were similar except for implant offset: one hip in each patient was replaced using a femoral component having a standard implant offset, whereas the other side had a lateral offset implant. The mean followup was 5.70 years (range, 2-10.2 years) on the side with a standard femoral implant and 5.67 years (range, 2-9.7 years) on the side with a lateralized femoral component. The only statistically different parameter between the sides was the femoral component offset. All other parameters affecting polyethylene wear, such as period of followup, head size, head type, cup size, cup inclination, medialization of cup, and patient-related factors were similar on both sides. On the side with a standard femoral component, the mean actual prosthetic offset (determined by manufacturer's specifications) was 35.2 mm and the radiologic offset was 31.5 mm. On the side with a lateralized femoral component, the actual prosthetic offset was 42.5 mm and the radiologic offset was 40.1 mm. The difference in offsets between the sides was statistically significant. The mean preoperative offset of the femur was 38.8 mm. Regression analysis revealed that only femoral component offset and cup size correlated significantly with linear wear rate. On the side with a standard femoral component, the linear wear rate was 0.21 mm per year, whereas on the side with a lateralized femoral component, the linear wear rate was 0.10 mm per year. The differences in the linear wear rates were significant. Lateralization of the femoral component in this series more closely restored preoperative hip biomechanics and significantly decreased polyethylene wear.

Total hip arthroplasty in patients on long-term renal dialysis.

End-stage renal failure patients on long-term renal dialysis who underwent total hip arthroplasty (THA) were followed. Fifteen hips were implanted in 12 patients. There was a high mortality (58%) and high overall early complication rate (58%) with a deep infection rate of 13%. Of patients, 76% (n = 11) had good clinicoradiologic outcome of the THA before their death or at their latest follow-up. THA in patients on dialysis, however, should be reserved for those among this group who are expected to have a better life expectancy.

Minimum 10-year results of a tapered cementless hip replacement.

Seventy-one total hip arthroplasties with a cementless, wedge fit, cobalt chrome femoral component were reviewed in 60 patients at a minimum 10-year followup (mean, 11.5 years). For the femoral component, the mechanical failure rate was 5% and the revision rate for aseptic loosening was 0%. The mean Charnley scores for pain, function, and motion changed from preoperative mean values of 3.0, 2.7, and 3.2 to followup mean values of 5.7, 5.5, and 5.2, respectively. The followup mean Harris hip Score was 91. The incidence of thigh pain was 1.4% at 10-year followup. Ninety-five percent of femoral components showed radiologic evidence of stable, bone ingrowth fixation, whereas loosening was seen in 5% of stems. Despite the high incidence of acetabular osteolysis, no osteolysis was seen on the femoral side distal to the lesser trochanter. Nonmodularity of the femoral component led to unavoidable revision of stably fixed femoral components in seven (9.8%) hips during the revision of a loose socket. Design features (collarless, tapered, wedge fit, and circumferentially porous coated) were thought to be crucial to the superlative results with the cobalt chrome femoral component.